Tag: FSFI

Sexual Function and Depressive Symptoms in Young Women with Hypothyroidism Receiving Levothyroxine/Liothyronine Combination Therapy: A Pilot Study

This quasi-randomized, single-blind pilot study investigated the effects of levothyroxine/liothyronine combination therapy versus levothyroxine monotherapy on sexual function and depressive symptoms in 39 premenopausal women with hypothyroidism who continued to experience symptoms despite normalized thyroid hormone levels. Over six months, the combination therapy group showed significant improvements in sexual desire

Read More »

Effect of a Multi-Ingredient Based Food Supplement on Sexual Function in Women with Low Sexual Desire

This exploratory, prospective, non-controlled observational study assessed the efficacy of Libicare®, a multi-ingredient food supplement, in improving sexual function among 29 postmenopausal women aged 45–65 with low sexual desire (FSFI < 25.83). Participants consumed two tablets daily for two months. Libicare® contains extracts of Trigonella foenum-graecum, Turnera diffusa, Tribulus terrestris,

Read More »

Assessment of sexuality among middle-aged women using the Female Sexual Function Index

This study explored sexual dysfunction in middle-aged women (ages 40-59), with 55.7% of participants reporting dysfunction, most commonly related to lubrication and pain. Significant risk factors included age, menopausal status, and partner-related issues such as erectile dysfunction and premature ejaculation. Healthcare providers should consider both personal and partner factors when

Read More »